Hillhouse Investment — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Axoft is developing soft, tissue-mimicking neural implants and supporting bidirectional electronics that record and stimulate brain activity through a minimally-invasive burr-hole procedure.
AI & Machine LearningDeep TechMedical DevicesCambridge, US
Paul Le Floch(Executive Officer, Director)inTianyang Ye(Director)inRachel Sha(Director)
BoardChia An Lee(Director)Benjamin Pless(Director)
Co-investorsArcherman CapitalBlindspot Ventures Management CoCastor Ventures (an Alumni Ventures Fund)Creative Destruction Lab (CDL)Safar PartnersThe Engine Ventures+2 more
Third Arc Bio develops breakthrough treatments in oncology and immunology through advanced biologics engineering.
BiotechMedical DevicesLower Gwynedd, US
Joseph Erhardt(Executive Officer)inPeter Lebowitz(Executive Officer, Director)
BoardArjun Goyal(Director)inOtello Stampacchia(Director)inFrancesco Draetta(Director)in
Co-investorsAndreessen HorowitzVida Venturesabrdn plcBiotechnology Value FundForesite CapitalOmega Funds+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.